Adverse Effects of Long-Term Oral Corticosteroids in the Department of Dermatology, Antananarivo, Madagascar

References

• Kapugi M, Cunningham K. Corticosteroids. Orthop Nurs. 2019;38(5):336–339. doi:10.1097/NOR.0000000000000595
   PubMed Web of Science ®Google Scholar
• Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: a systemic literature review. Clin Ther. 2017;39:2216–2229. doi:10.1016/j.clinthera.2017.09.011
   PubMed Web of Science ®Google Scholar
• Chemical Book. Hydrocortisone (50-23-7); 2008. Available from: http://www.chemicalbook.com/ProdSupplierGNCB9756715_EN.htm. Accessed January 30, 2014.
   Google Scholar
• Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid induced adverse events in adults: frequency, screening and prevention. Drug Safety. 2007;30(10):861–881. doi:10.2165/00002018-200730100-00005
   PubMed Web of Science ®Google Scholar
• Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol. 2009;23:769–779. doi:10.1016/j.berh.2009.09.006
   PubMed Web of Science ®Google Scholar
• Nassar K, Janani S, Roux C, Rachidi W, Etaouil N, Mkinsi O. La corticothérapie systémique au long cours: representations des patients, perceptions des prescripteurs et observance thérapeutique[Long-term systemic glucocorticoid therapy: patient's representations, prescriber's perceptions, and treatment adherence]. Rev Rhum. 2014;81(1):49–53. doi:10.1016/j.rhum.2013.04.008
   Google Scholar
• Zomalheto Z, Dossou-yovo H, Zossoungbo F, Avimadjè M. Prévalence des complications de la corticothérapie chez les sujets ouest-africains consultant en rhumatologie[Prevalence of complications of corticosteroid therapy among West African consulting in rheumatology]. PAMJ. 2015;21:304. doi:10.11604/pamj.2015.21.304.5805
   Google Scholar
• Dubois EF, Roder R, Dekhuijzen PN, Zwinderman AE, Schweitzer DH. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. Chest. 2002;121:1456–1463. doi:10.1378/chest.121.5.1456
   Web of Science ®Google Scholar
• Lefebvre P, Duh MS, Lafeuille MH, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136:1488–1495. doi:10.1016/j.jaci.2015.07.046
   PubMed Web of Science ®Google Scholar
• Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology. 2000;39:1383–1389. doi:10.1093/rheumatology/39.12.1383
   PubMed Web of Science ®Google Scholar
• Fiches modèles OMS d’information à l’usage des prescripteurs: médicaments utilisés dans les mycobactérioses[WHO model prescribing information: drugs used in mycobacteral diseases]; 1993. Available from: https://apps.who.int/medicinedocs/en/d/Js5512f/4.1.html. Accessed September 13, 2021.
   Google Scholar
• Roden DM. Predicting drug-induced QT prolongation and torsade de pointes. J Physiol. 2016;594:2459–2468. doi:10.1113/JP270526
   PubMed Web of Science ®Google Scholar
• Hajiroussou VJ, Webley M. Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis. 1984;43(1):24–27. doi:10.1136/ard.43.1.24
   Web of Science ®Google Scholar
• Narum S, Westergren T, Klemp M. Corticosteroids and riskof gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014. 4. e004587.
   PubMed Web of Science ®Google Scholar
• Martindale. The complete drug reference. Accessed through medicines complete. Available from: https://www.medicinescomplete.com/mc/martindale/current/1060-a2-n.htm. Accessed September 13, 2021.
   Google Scholar
• Fardet L, Flahault A, Kettaneh A, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol. 2007;157(1):142–148. doi:10.1111/j.1365-2133.2007.07950.x
   PubMed Web of Science ®Google Scholar
• Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis. 2009;68:1833–1838. doi:10.1136/ard.2008.100008
   PubMed Web of Science ®Google Scholar
• Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–1367. doi:10.4065/81.10.1361
   PubMed Web of Science ®Google Scholar
• Kenna HA, Poon AW, de Los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci. 2011;65:549–560. doi:10.1111/j.1440-1819.2011.02260.x
   PubMed Web of Science ®Google Scholar
• Laouar L, Makhloufi M. Les troubles neuropsychiatriques et corticothérapie systémique[Neuropsychiatric disorders and systemic corticosteroids in 72 patients]. Rev Mal Resp. 2016;33:A121–22. doi:10.1016/j.rmr.2015.10.206
   Google Scholar
• Gennari FJ. Hypokaliemia. N Engl J Med. 1998;339(7):451–458. doi:10.1056/NEJM199808133390707
   PubMed Web of Science ®Google Scholar
• Roshni PR, Saikeerthana PC, Krishna PR. Steroid induced hypokalemia: a case report. J Pharm Sci Rev Res. 2017;42(1):42–43.
   Google Scholar
• Mills E, Devendra S. Steroid-induced hyperglycaemia in primary care. London J Prim Care (Abingdon). 2015;7:103–106. doi:10.1080/17571472.2015.1082344
   PubMed Web of Science ®Google Scholar
• van Raalte DH, van Genugten RE, Linssen MM, Ouwens DM, Diamant M. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. Diabetes Care. 2011;34:412–417. doi:10.2337/dc10-1677
   PubMed Web of Science ®Google Scholar
• Liu XX, Zhu XM, Miao Q, Ye HY, Zhang ZY, Li YM. Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab. 2014;65:324–332. doi:10.1159/000365892
   PubMed Web of Science ®Google Scholar
• Katsuyama T, Sada KE, Namba S, et al. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Res Clin Pract. 2015;108(2):273–279. doi:10.1016/j.diabres.2015.02.010
   PubMed Web of Science ®Google Scholar
• Kim SY, Yoo C-G, Lee CT, et al. Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease. J Korean Med Sci. 2011;26(2):264–267. doi:10.3346/jkms.2011.26.2.264
   PubMed Web of Science ®Google Scholar